SCHW vs TCRX · P/E 19, rev $13.55B vs rev $2.0M
Charles Schwab Corp (SCHW) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
SCHW currently screens at market cap $164.37B and trailing P/E 18.8. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the SCHW and TCRX stock pages for the full models.
Not investment advice.